- Company Overview for PANDEIA THERAPEUTICS LIMITED (11463856)
- Filing history for PANDEIA THERAPEUTICS LIMITED (11463856)
- People for PANDEIA THERAPEUTICS LIMITED (11463856)
- Registers for PANDEIA THERAPEUTICS LIMITED (11463856)
- More for PANDEIA THERAPEUTICS LIMITED (11463856)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
26 Sep 2024 | AA | Accounts for a small company made up to 31 December 2023 | |
26 Jun 2024 | CS01 | Confirmation statement made on 26 June 2024 with no updates | |
30 Apr 2024 | AD01 | Registered office address changed from C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH United Kingdom to The Cambridge Partnership the Dorothy Hodgkin Bldg Babraham Research Campus Babraham Cambridge CB22 3FH on 30 April 2024 | |
29 Apr 2024 | AP01 | Appointment of Jennifer Rhodes as a director on 26 April 2024 | |
29 Apr 2024 | TM01 | Termination of appointment of Austin Kim as a director on 26 April 2024 | |
06 Dec 2023 | AA01 | Current accounting period extended from 31 August 2023 to 31 December 2023 | |
04 Jul 2023 | CS01 | Confirmation statement made on 26 June 2023 with updates | |
28 Jun 2023 | AD02 | Register inspection address has been changed from 29a Rectory Lane Rectory Lane Lymm WA13 0AJ England to The Cambridge Partnership the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH | |
28 Jun 2023 | PSC02 | Notification of Acadia Pharmaceuticals Inc. as a person with significant control on 22 December 2022 | |
04 Jan 2023 | AP01 | Appointment of Austin Kim as a director on 22 December 2022 | |
04 Jan 2023 | MA | Memorandum and Articles of Association | |
04 Jan 2023 | RESOLUTIONS |
Resolutions
|
|
03 Jan 2023 | TM01 | Termination of appointment of John Fraser Murray as a director on 22 December 2022 | |
03 Jan 2023 | TM01 | Termination of appointment of David John Grainger as a director on 22 December 2022 | |
03 Jan 2023 | TM01 | Termination of appointment of Francesco De Rubertis as a director on 22 December 2022 | |
03 Jan 2023 | PSC07 | Cessation of Medicxi Ventures I Lp as a person with significant control on 22 December 2022 | |
05 Oct 2022 | AA | Accounts for a small company made up to 31 August 2022 | |
03 Aug 2022 | AA01 | Current accounting period shortened from 31 December 2022 to 31 August 2022 | |
27 Jun 2022 | CS01 | Confirmation statement made on 26 June 2022 with updates | |
19 May 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 8 September 2021
|
|
24 Mar 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
07 Oct 2021 | SH01 |
Statement of capital following an allotment of shares on 8 September 2021
|
|
30 Jul 2021 | CS01 | Confirmation statement made on 26 June 2021 with updates | |
16 Feb 2021 | AA | Total exemption full accounts made up to 31 December 2020 | |
01 Dec 2020 | SH01 |
Statement of capital following an allotment of shares on 30 November 2020
|